Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLB-3 in Total Hip Arthroplasty
NCT04555291Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jan 2022
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Opioid consumption at 24 hours. Started Jan 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04555291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04555291.